PATENT CLAIM ANALYSIS

Application Number: 16072382
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["800", "008000"]

Abstract:
The invention provides methods of treating schizophrenia in a subject, including for example, administering to the subject an agent that inhibits expression or activity of a C4A polynucleotide or polypeptide. The invention also provides methods of identifying a subject having or at risk of developing schizophrenia involving measuring or detecting an alteration in the level, copy number, and/or sequence of complement component C4A or complement component C4B relative to a reference.

Claim (Index 34):
An expression vector comprising an polynucleotide encoding complement component 4A (C4A).

Metadata:
- Claim Count in Document: 31.0
- Percentile: 95.0
- Lexical Diversity: 1.60417
- Patent Class: 800.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15029224', '14388791', '10107604', '10222945', '10150821']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5851914662130558
- 35 USC 102 Novelty (BERT): 0.4836888398923298
- Combined Prediction Score: 0.5750412035809833
- Mean Citation Score: 207.578086
- Max Citation Score: 218.4893
- Similarity Product: 151.34999263905286

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test